Lipid-Metabolism and Fat-Oxidation Research

• AOD9604 is a synthetic peptide fragment (amino acids 177–191) of human growth hormone (hGH) studied in cellular and pre-clinical systems for its ability to stimulate lipolysis and inhibit lipogenesis without activating the full growth-hormone receptor pathway.

Body-Composition and Energy-Expenditure Studies

• In animal models, AOD9604 has been observed to increase fatty-acid oxidation, elevate metabolic rate, and reduce adipose-tissue mass, making it a valuable tool for investigating energy balance and metabolic regulation.

Glucose-Homeostasis and Insulin-Sensitivity Models

• Research indicates that AOD9604 does not significantly alter insulin sensitivity or glucose tolerance, allowing isolated study of metabolic and adipolytic pathways independent of GH-mediated glycemic effects.

Cartilage and Joint-Regeneration Studies

• Laboratory data suggest AOD9604 may enhance chondrocyte activity and cartilage repair, providing a model for exploring joint regeneration, connective-tissue healing, and degenerative-joint conditions.

Muscle-Preservation and Catabolism-Resistance Research

• Pre-clinical findings demonstrate that AOD9604 can help preserve lean muscle mass during calorie restriction or energy deficit, enabling research on muscle maintenance and metabolic adaptation.

Growth-Factor and IGF-1 Pathway Independence

• AOD9604 acts independently of the IGF-1 axis, making it an ideal compound for studies focused on metabolic modulation without the proliferative effects linked to full-length GH analogs.

Recovery and Tissue-Repair Models

• In experimental systems, AOD9604 has been shown to promote tissue regeneration and mitochondrial efficiency, offering a basis for research into post-exercise recovery and wound-healing dynamics.

Safety and Toxicology Findings

• Across multiple in-vitro and animal studies, AOD9604 has demonstrated a favorable toxicological profile, with no reported impact on serum IGF-1 or glucose metabolism under controlled conditions.